Lung Cancer
    
    
  
  Article
Lung adenocarcinomas: mutations you don’t want to miss
Conference Coverage
Clinical advances drive lung cancer staging, classification changes
Key clinical point: Improved understanding of lung cancer over the last decade has prompted updates to international tumor staging and...
News
New cancer cases to reach nearly 2.4 million in 2035 – AACR
News
Nivolumab benefits heavily pretreated squamous NSCLC patients
Key clinical point: Nivolumab was associated with improved survival among patients with heavily pretreated squamous cell NSCLC. Major finding: 1-...
News
Chemotherapy plus cetuximab shows OS benefit in squamous NSCLC
Key clinical point:Adding cetuximab to chemotherapy improved overall survival in patients with squamous cell non–small cell lung cancer with high...
Conference Coverage
Share of lung cancer patients who never smoked is rising
Key clinical point: The proportion of patients with lung cancer who have never smoked has risen in recent decades. Major finding: Between 1990 and...
Conference Coverage
IASLC issues new tobacco declaration
The 2015 IASLC declaration has five components that address tobacco control and smoking cessation.
News
Hunger hormone mimic anamorelin treats cachexia in NSCLC
Key clinical point: The ghrelin receptor agonist anamorelin helped patients with cancer cachexia gain lean body mass. Major finding: Patients...
Conference Coverage
Workshop tackles finer points of lung cancer screening
News
Nivolumab continues to offer better survival for squamous NSCLC patients
Key clinical point: The checkpoint inhibitor nivolumab provides a survival advantage over docetaxel in advanced squamous non–small cell lung...
 
                             